We observed significantly increased plasma levels of NEAT1 in the MCI and ad-AD subgroups compared to that of the control group (p=0.003 and p=0.002, respectively Figure 3a(Fig. 3)), but the differences between the AD subgroups were not statistically significant (Figure 3(Fig. 3)). The gene discussed is NEAT1; the disease is Alzheimer disease.